Literature DB >> 1735188

Antibodies to acetylcholine receptors in myasthenia gravis. In vitro synthesis by peripheral blood lymphocytes before and after thymectomy.

J B Kuks1, P C Limburg, H J Oosterhuis, T H The.   

Abstract

Pokeweed mitogen (PWM)-driven in vitro synthesis of antibodies to the acetylcholine receptor (PSA) was studied in non-thymoma patients with myasthenia gravis. In a group of 46 patients, the occurrence of PSA was related to the presence of the thymus or, in operated patients, the absence of a clinical effect of thymectomy. Sixteen patients were followed before and soon after thymectomy. PSA disappeared in all patients, at least temporarily, between 6 weeks and 1 year afterwards, independent of the clinical course and eventual clinical effect of the operation. A recurrence was found only in one of the five patients who derived no benefit from the operation. These findings support the hypothesis that the therapeutic effect of thymectomy can be explained by removal of a source of autoreactive lymphocytes. There was no correlation between the changes in serum levels of a-AChR and clinical improvement, suggesting a minor role of circulating peripheral blood lymphocytes (PBL) and the thymus in the total production of a-AChR.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1735188      PMCID: PMC1554251          DOI: 10.1111/j.1365-2249.1992.tb02982.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  28 in total

1.  Anti-acetylcholine receptor antibodies decrease after thymectomy in patients with myasthenia gravis. Clinical correlations.

Authors:  J B Kuks; H J Oosterhuis; P C Limburg; T H The
Journal:  J Autoimmun       Date:  1991-04       Impact factor: 7.094

2.  Circulating CD4+CD8+ cells in myasthenia gravis: supplementary immunological parameter for long-term prognosis.

Authors:  M Matsui; H Fukuyama; I Akiguchi; M Kameyama
Journal:  J Neurol       Date:  1989-09       Impact factor: 4.849

3.  Immunological heterogeneity and cellular mechanisms in myasthenia gravis.

Authors:  J Newsom-Davis; N Willcox; M Schluep; G Harcourt; A Vincent; S Mossman; D Wray; J Burges
Journal:  Ann N Y Acad Sci       Date:  1987       Impact factor: 5.691

4.  Thymus in myasthenia gravis. Isolation of T-lymphocyte lines specific for the nicotinic acetylcholine receptor from thymuses of myasthenic patients.

Authors:  A Melms; B C Schalke; T Kirchner; H K Müller-Hermelink; E Albert; H Wekerle
Journal:  J Clin Invest       Date:  1988-03       Impact factor: 14.808

5.  Effect of thymectomy on blood T-cell subsets in myasthenia gravis.

Authors:  A Cox; R P Lisak; P Skolnik; B Zweiman
Journal:  Ann Neurol       Date:  1986-03       Impact factor: 10.422

6.  In vitro synthesis of IgG and antibodies to AChR by peripheral and thymic lymphocytes.

Authors:  R P Lisak; A I Levinson; B Zweiman; M J Kornstein
Journal:  Ann N Y Acad Sci       Date:  1987       Impact factor: 5.691

7.  Cell types required for anti-acetylcholine receptor antibody synthesis by cultured thymocytes and blood lymphocytes in myasthenia gravis.

Authors:  H N Willcox; J Newsom-Davis; L R Calder
Journal:  Clin Exp Immunol       Date:  1984-10       Impact factor: 4.330

8.  Myasthenic thymus and thymoma are selectively enriched in acetylcholine receptor-reactive T cells.

Authors:  N Sommer; N Willcox; G C Harcourt; J Newsom-Davis
Journal:  Ann Neurol       Date:  1990-09       Impact factor: 10.422

9.  Enhanced activation of a T cell line specific for acetylcholine receptor (AChR) by using anti-AChR monoclonal antibodies plus receptors.

Authors:  B C Schalke; W E Klinkert; H Wekerle; D S Dwyer
Journal:  J Immunol       Date:  1985-06       Impact factor: 5.422

10.  In vitro T-cell dependent B-cell activity in myasthenia gravis.

Authors:  P C Limburg; E Hummel-Tappel; H J Oosterhuis; T H The
Journal:  Clin Exp Immunol       Date:  1985-07       Impact factor: 4.330

View more
  1 in total

Review 1.  Myasthenia gravis: an autoimmune response against the acetylcholine receptor.

Authors:  Y M Graus; M H De Baets
Journal:  Immunol Res       Date:  1993       Impact factor: 2.829

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.